Discover 1,342 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,342
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
for
Intracranial Arteriosclerosis, Stroke
Location: 77 recruiting locations
Sponsor: University of Florida
Sex: All
Age: 30+
Code: NCT05047172
Phase3, Recruiting
Active & Responsive
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Get alerts for new trials in your area by subscribing now
Active & Responsive
Accelerated Resolution Therapy for Early Maladaptive Grief
for
Grief
Location: 4 recruiting locations
Sponsor: Mayo Clinic
Sex: All
Age: 60+
Code: NCT05624879
Recruiting
Active & Responsive
Study of Screening Brain MRIs in Stage IV Breast Cancer
for
Triple Negative Breast Cancer, HER2-positive Breast Cancer,
Location: 1 recruiting location
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05115474
Recruiting
Active & Responsive
SELUTION 4 De Novo Small Vessel IDE Trial
for
Coronary Artery Disease
Location: 36 recruiting locations
Sponsor: M.A. Med Alliance S.A.
Sex: All
Age: 18+
Code: NCT05946629
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: 28 recruiting locations
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease